IRVINE, Calif., June 19, 2017 (GLOBE NEWSWIRE) -- Khang & Khang LLP (the "Firm") announces a securities class action lawsuit against Ocwen Financial Corporation ("Ocwen" or the "Company") OCN. Investors who purchased or otherwise acquired shares between January 13, 2015 and April 20, 2017, inclusive (the "Class Period"), are encouraged to contact the Firm by the June 20, 2017 lead plaintiff motion deadline.
If you purchased Ocwen shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.
There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may take no action and remain a passive class member as well.
The Complaint alleges that throughout the Class Period, Ocwen made false and/or misleading statements and/or failed to disclose: that the Company engaged in significant and systemic misconduct at almost every stage of the mortgage servicing process; that this conduct exposed Ocwen to heightened regulatory scrutiny and potential criminal sanctions; and that as a result of the above, the Company's public statements were materially false and misleading at all relevant times. On April 20, 2017, the Consumer Financial Protection Bureau announced that it was suing Ocwen, and several states issued cease-and-desist orders against the Company. Following this news, Ocwen's stock price dropped materially, which caused investors harm according to the Complaint.
If you wish to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.
This press release may be considered Attorney Advertising in some jurisdictions.
Contact Joon M. Khang, Esq. Telephone: 949-419-3834 Facsimile: 949-225-4474 joon@khanglaw.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.